Do Not Perform Equipment Cleaning During Active Batch Processing
Remember: GMP prohibits equipment cleaning during active batch production—this can lead to cross-contamination, misdocumentation, and product rejection.
Why This Matters in GMP
Once a batch is in process, any cleaning activity—internal or external—on the associated equipment can disrupt process control, introduce moisture or cleaning agents, or compromise traceability. It creates ambiguity around which product residues belong to which batch and challenges the integrity of manufacturing records. This practice is also prone to undocumented changes or missed cleaning steps. GMP mandates that equipment cleaning occur only before or after production, not concurrently, to preserve batch identity and ensure clear documentation.
Regulatory and Compliance Implications
FDA 21 CFR Part 211.67(a) specifies that equipment must be cleaned before use and between batches, not during processing. EU GMP Chapter 5 requires equipment to be free of residues and clean before production starts. WHO GMP and Schedule M emphasize process segregation and equipment status controls. Auditors review equipment logbooks, batch manufacturing records (BMRs), and cleaning records. Overlapping cleaning and manufacturing timelines are red flags and may trigger CAPA or investigation demands.
Implementation Best Practices
- Clearly indicate equipment status using visual tags
Regulatory References
- FDA 21 CFR Part 211.67 – Equipment Cleaning and Use Controls
- EU GMP Chapter 5 – Equipment and Process Control
- WHO GMP – Production Hygiene and Equipment Status
- Schedule M – Cleaning Timing and Batch Segregation